Company Filing History:
Years Active: 2012-2018
Title: Angelika Bonauer – Innovator in Angiogenesis Research
Introduction
Angelika Bonauer is a noted inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of angiogenesis research, particularly with her innovative approaches to influencing miR-92 expression in cells. With a total of four patents to her name, her work is pivotal in both therapeutic angiogenesis and tumor inhibition.
Latest Patents
Bonauer's latest patents focus on methods for the inhibition of angiogenesis. These inventions detail a method that involves influencing miR-92 expression in cells through two main approaches. The first approach consists of reducing miR-92 expression by introducing an antisense molecule into the cell, aiming to promote vascularization or vessel repair. The second approach involves increasing miR-92 expression using a construct that includes an expressible miR-92 sequence, which is intended to inhibit tumor angiogenesis. Additionally, these patents include pharmaceutical compositions that utilize either antisense molecules or constructs to regulate miR-92 activity, highlighting their potential therapeutic applications.
Career Highlights
Angelika Bonauer has worked with notable companies such as T2Cure GmbH and Johann Wolfgang Goethe-University Frankfurt am Main. Her positions at these institutions have facilitated her research, enabling her to explore innovative strategies for treating angiogenesis-related conditions effectively.
Collaborations
Throughout her career, Bonauer has collaborated with esteemed colleagues, including Stefanie Dimmeler and Andreas Michael Zeiher. These collaborations have been essential in advancing her research and enhancing the impact of her inventions in the medical field.
Conclusion
Angelika Bonauer's contributions to the study of angiogenesis and her patented methods for regulating miR-92 expression demonstrate her role as a leading innovator in her field. Her work not only advances scientific understanding but also holds promise for developing new therapeutic strategies against various vascular and tumor-related diseases.